A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma

Clinical trial NCT05886634 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05886634
Sponsor: Memorial Sloan Kettering Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Dedifferentiated Liposarcoma Soft Tissue Sarcoma Sarcoma,Soft Tissue Sarcoma Recurrent Dedifferentiated Liposarcoma Unresectable Dedifferentiated Liposarcoma Metastatic Dedifferentiated Liposarcoma

Start date: 2023-05-23
Primary completion: 2027-05-23
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.